Goldhirsch, ARefine your research by the most used items
Author / Editor
- Borner, M M (2)
- Fazio, N (2)
- Herrmann, R (2)
- Maibach, R (2)
- Morant, R (2)
- Roth, Arnaud (2)
- Aapro, M S (1)
- Alberto, Pierre (1)
- Castiglione, M (1)
- Cavalli, F (1)
Document type
Full text accessibility
Full text version
Subject
- Humans (2)
- Survival analysis (2)
- Adenocarcinoma/drug therapy/mortality/secondary (1)
- Adult (1)
- Aged (1)
- Antineoplastic combined chemotherapy protocols/adverse effects/therapeutic use (1)
- Antineoplastic combined chemotherapy protocols/therapeutic use (1)
- Carcinoma/drug therapy/pathology (1)
- Cisplatin/administration & dosage (1)
- Cisplatin/administration & dosage/adverse effects (1)
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial | Roth, Arnaud; Maibach, R; Fazio, N; Sessa, C; ... de Braud, F | 2004 |
|
|
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) | Roth, Arnaud; Maibach, R; Martinelli, G; Fazio, N; ... Goldhirsch, A | 2000 |
